Atrium Therapeutics Inc (RNA)

EBITDA Margin

-404.56%

TTM · Period ending:

RNA logo

RNA EBITDA Margin

Latest reported-404.56%
RNA EBITDA Margin (-410.91% → -404.56%)
High-resolution chart · PNG

RNA ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-410.9088%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.